DD91496B3 - Verfahren zur herstellung neuer penicilline - Google Patents
Verfahren zur herstellung neuer penicilline Download PDFInfo
- Publication number
- DD91496B3 DD91496B3 DD71155308A DD15530871A DD91496B3 DD 91496 B3 DD91496 B3 DD 91496B3 DD 71155308 A DD71155308 A DD 71155308A DD 15530871 A DD15530871 A DD 15530871A DD 91496 B3 DD91496 B3 DD 91496B3
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- parts
- acid
- weight
- methyl
- benzylpenicillin
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 24
- 230000008569 process Effects 0.000 title claims description 5
- IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 title 1
- -1 chloro, bromo, iodo Chemical group 0.000 claims description 141
- 229930182555 Penicillin Natural products 0.000 claims description 100
- 239000000203 mixture Substances 0.000 claims description 67
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 claims description 63
- 150000002960 penicillins Chemical class 0.000 claims description 61
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 claims description 58
- 238000006243 chemical reaction Methods 0.000 claims description 35
- 239000002904 solvent Substances 0.000 claims description 29
- 125000004432 carbon atom Chemical group C* 0.000 claims description 27
- 125000000217 alkyl group Chemical group 0.000 claims description 25
- 150000001875 compounds Chemical class 0.000 claims description 23
- 150000001735 carboxylic acids Chemical class 0.000 claims description 18
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 17
- 125000003282 alkyl amino group Chemical group 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 150000002431 hydrogen Chemical group 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 125000004423 acyloxy group Chemical group 0.000 claims description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 5
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 4
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 4
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 150000002825 nitriles Chemical class 0.000 claims description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 4
- 231100000252 nontoxic Toxicity 0.000 claims description 4
- 230000003000 nontoxic effect Effects 0.000 claims description 4
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000003609 aryl vinyl group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 claims description 2
- 229910052717 sulfur Chemical group 0.000 claims description 2
- 239000011593 sulfur Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 239000003125 aqueous solvent Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 163
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 135
- 229940056360 penicillin g Drugs 0.000 description 122
- 239000000243 solution Substances 0.000 description 85
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 73
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 70
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 68
- 229940049954 penicillin Drugs 0.000 description 66
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 57
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 47
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 42
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 40
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 37
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 37
- 159000000000 sodium salts Chemical class 0.000 description 31
- 239000002253 acid Substances 0.000 description 29
- UWMLSXCBFHQUTH-UHFFFAOYSA-M [chloro(dimethylamino)methylidene]-dimethylazanium;chloride Chemical compound [Cl-].CN(C)C(Cl)=[N+](C)C UWMLSXCBFHQUTH-UHFFFAOYSA-M 0.000 description 25
- 239000011734 sodium Substances 0.000 description 24
- 238000003756 stirring Methods 0.000 description 24
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 23
- 239000000047 product Substances 0.000 description 23
- 229910052708 sodium Inorganic materials 0.000 description 23
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 22
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 22
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- 229960000583 acetic acid Drugs 0.000 description 20
- 229960003424 phenylacetic acid Drugs 0.000 description 18
- 239000003279 phenylacetic acid Substances 0.000 description 18
- 239000012074 organic phase Substances 0.000 description 16
- 235000019371 penicillin G benzathine Nutrition 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 15
- 241000588724 Escherichia coli Species 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 13
- 239000004471 Glycine Substances 0.000 description 13
- 238000001816 cooling Methods 0.000 description 13
- 238000002329 infrared spectrum Methods 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 12
- 229960000723 ampicillin Drugs 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 12
- 239000002585 base Substances 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 10
- 241000588769 Proteus <enterobacteria> Species 0.000 description 10
- 230000007717 exclusion Effects 0.000 description 10
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 241000588748 Klebsiella Species 0.000 description 7
- 241000589516 Pseudomonas Species 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 6
- 150000002923 oximes Chemical class 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- VYPDUQYOLCLEGS-UHFFFAOYSA-M sodium;2-ethylhexanoate Chemical compound [Na+].CCCCC(CC)C([O-])=O VYPDUQYOLCLEGS-UHFFFAOYSA-M 0.000 description 6
- 150000003952 β-lactams Chemical class 0.000 description 6
- RYKRJTNGEUPJLS-UHFFFAOYSA-N 5-chloro-1-methyl-2,3-dihydropyrrole;hydrochloride Chemical compound [Cl-].C[NH+]1CCC=C1Cl RYKRJTNGEUPJLS-UHFFFAOYSA-N 0.000 description 5
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- RWQSNJNTGSUNOR-UHFFFAOYSA-N methyl n-carbonochloridoyl-n-methylcarbamate Chemical compound COC(=O)N(C)C(Cl)=O RWQSNJNTGSUNOR-UHFFFAOYSA-N 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 125000001544 thienyl group Chemical group 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229950005499 carbon tetrachloride Drugs 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 238000007911 parenteral administration Methods 0.000 description 4
- 239000012429 reaction media Substances 0.000 description 4
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 3
- NXJZQSRAFBHNLI-UHFFFAOYSA-N 2-oxoimidazolidine-1-carbonyl chloride Chemical compound ClC(=O)N1CCNC1=O NXJZQSRAFBHNLI-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 3
- YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical compound OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- NSRQMKGETWBHOL-UHFFFAOYSA-N 2-(4-methylphenyl)-2-[(2-oxoimidazolidine-1-carbonyl)amino]acetic acid Chemical compound C1=CC(C)=CC=C1C(C(O)=O)NC(=O)N1C(=O)NCC1 NSRQMKGETWBHOL-UHFFFAOYSA-N 0.000 description 2
- VUAXTPSEPYFWMU-UHFFFAOYSA-N 2-[[dimethylcarbamoyl(methyl)carbamoyl]amino]-2-(4-methoxyphenyl)acetic acid Chemical compound COC1=CC=C(C(NC(=O)N(C)C(=O)N(C)C)C(O)=O)C=C1 VUAXTPSEPYFWMU-UHFFFAOYSA-N 0.000 description 2
- LLMMHEFASBYAHM-UHFFFAOYSA-N 2-[[dimethylcarbamoyl(methyl)carbamoyl]amino]-2-phenylacetic acid Chemical compound CN(C)C(=O)N(C)C(=O)NC(C(O)=O)C1=CC=CC=C1 LLMMHEFASBYAHM-UHFFFAOYSA-N 0.000 description 2
- QSEYPFSNAIDYGX-UHFFFAOYSA-N 2-[[methoxycarbonyl(methyl)carbamoyl]amino]-2-(4-methoxyphenyl)acetic acid Chemical compound COC(=O)N(C)C(=O)NC(C(O)=O)C1=CC=C(OC)C=C1 QSEYPFSNAIDYGX-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- CCCCVCPAIMYNLU-LLVKDONJSA-N CC(C)OC(=O)N(C)C(=O)N[C@@H](C(O)=O)C1=CC=CC=C1 Chemical compound CC(C)OC(=O)N(C)C(=O)N[C@@H](C(O)=O)C1=CC=CC=C1 CCCCVCPAIMYNLU-LLVKDONJSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000012431 aqueous reaction media Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- MLAGRZNCHYHIBW-UHFFFAOYSA-N cyclohexyl n-carbonochloridoyl-n-methylcarbamate Chemical compound ClC(=O)N(C)C(=O)OC1CCCCC1 MLAGRZNCHYHIBW-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- YECZTTHHUYWDCA-UHFFFAOYSA-N dimethyl-[1-(methylamino)ethylidene]azanium;chloride Chemical compound [Cl-].CNC(C)=[N+](C)C YECZTTHHUYWDCA-UHFFFAOYSA-N 0.000 description 2
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- BCDGQXUMWHRQCB-UHFFFAOYSA-N glycine methyl ketone Natural products CC(=O)CN BCDGQXUMWHRQCB-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 125000004498 isoxazol-4-yl group Chemical group O1N=CC(=C1)* 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- WQNZKMJHQBIKKO-UHFFFAOYSA-N n,n'-dimethyl-n,n'-bis(trimethylsilyl)ethane-1,2-diamine Chemical compound C[Si](C)(C)N(C)CCN(C)[Si](C)(C)C WQNZKMJHQBIKKO-UHFFFAOYSA-N 0.000 description 2
- KARPAXFMDRDIJO-UHFFFAOYSA-N n-(dimethylcarbamoyl)-n-methylcarbamoyl chloride Chemical compound CN(C)C(=O)N(C)C(Cl)=O KARPAXFMDRDIJO-UHFFFAOYSA-N 0.000 description 2
- KTJVZEYNPCIDBG-UHFFFAOYSA-N n-benzoyl-n-methylcarbamoyl chloride Chemical compound ClC(=O)N(C)C(=O)C1=CC=CC=C1 KTJVZEYNPCIDBG-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical group 0.000 description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000010414 supernatant solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RIBVLAYWEVCPJK-GFCCVEGCSA-N (2R)-2-[[4-chlorobutanoyl(methyl)carbamoyl]amino]-2-phenylacetic acid Chemical compound ClCCCC(=O)N(C(N[C@@H](C(=O)O)C1=CC=CC=C1)=O)C RIBVLAYWEVCPJK-GFCCVEGCSA-N 0.000 description 1
- CSCPPACGZOOCGX-MICDWDOJSA-N 1-deuteriopropan-2-one Chemical compound [2H]CC(C)=O CSCPPACGZOOCGX-MICDWDOJSA-N 0.000 description 1
- FOTKDKHMRQKYHB-UHFFFAOYSA-N 2-(2,4-dibromophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C(Br)C=C1Br FOTKDKHMRQKYHB-UHFFFAOYSA-N 0.000 description 1
- KEMXLCXNWVNHEP-UHFFFAOYSA-N 2-(2,6-dichlorophenyl)-2-[[methoxycarbonyl(methyl)carbamoyl]amino]acetic acid Chemical compound COC(=O)N(C)C(=O)NC(C(O)=O)C1=C(Cl)C=CC=C1Cl KEMXLCXNWVNHEP-UHFFFAOYSA-N 0.000 description 1
- PJOFKTMGWQRYET-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-[(2-oxoimidazolidine-1-carbonyl)amino]acetic acid Chemical compound C=1C=C(Cl)C=CC=1C(C(=O)O)NC(=O)N1CCNC1=O PJOFKTMGWQRYET-UHFFFAOYSA-N 0.000 description 1
- AJWPLLBVVIDWRH-UHFFFAOYSA-N 2-(4-methylsulfanylphenyl)-2-[(2-oxoimidazolidine-1-carbonyl)amino]acetic acid Chemical compound C1=CC(SC)=CC=C1C(C(O)=O)NC(=O)N1C(=O)NCC1 AJWPLLBVVIDWRH-UHFFFAOYSA-N 0.000 description 1
- IBNGINOWZUSNBC-UHFFFAOYSA-N 2-(carbamoylamino)-4-methoxy-4-oxo-2-phenylbutanoic acid Chemical compound COC(=O)CC(NC(N)=O)(C(O)=O)C1=CC=CC=C1 IBNGINOWZUSNBC-UHFFFAOYSA-N 0.000 description 1
- VJIBYXPWCAWSDY-UHFFFAOYSA-N 2-(thiophen-2-ylmethylazaniumyl)acetate Chemical compound [O-]C(=O)C[NH2+]CC1=CC=CS1 VJIBYXPWCAWSDY-UHFFFAOYSA-N 0.000 description 1
- IUHWCKNZDNHFRH-UHFFFAOYSA-N 2-[[acetyl(benzyl)carbamoyl]amino]-2-phenylacetic acid Chemical compound C=1C=CC=CC=1C(C(O)=O)NC(=O)N(C(=O)C)CC1=CC=CC=C1 IUHWCKNZDNHFRH-UHFFFAOYSA-N 0.000 description 1
- HOLILTCPXLZRMK-UHFFFAOYSA-N 2-[[acetyl(methyl)carbamoyl]amino]-2-(2,4-dibromophenyl)acetic acid Chemical compound CC(=O)N(C)C(=O)NC(C(O)=O)C1=CC=C(Br)C=C1Br HOLILTCPXLZRMK-UHFFFAOYSA-N 0.000 description 1
- OCOFBGDISJUFAQ-UHFFFAOYSA-N 2-[[acetyl(methyl)carbamoyl]amino]-2-(2,6-dichlorophenyl)acetic acid Chemical compound CC(=O)N(C)C(=O)NC(C(O)=O)C1=C(Cl)C=CC=C1Cl OCOFBGDISJUFAQ-UHFFFAOYSA-N 0.000 description 1
- YHFAEBAWEGSAKE-UHFFFAOYSA-N 2-[[acetyl(methyl)carbamoyl]amino]-2-(2,6-dimethoxyphenyl)acetic acid Chemical compound COC1=CC=CC(OC)=C1C(NC(=O)N(C)C(C)=O)C(O)=O YHFAEBAWEGSAKE-UHFFFAOYSA-N 0.000 description 1
- FDIKRGNZCLXSMA-UHFFFAOYSA-N 2-[[acetyl(methyl)carbamoyl]amino]-2-(2-chloro-6-fluorophenyl)acetic acid Chemical compound CC(=O)N(C)C(=O)NC(C(O)=O)C1=C(F)C=CC=C1Cl FDIKRGNZCLXSMA-UHFFFAOYSA-N 0.000 description 1
- XSSSFECLQZXBHD-UHFFFAOYSA-N 2-[[benzoyl(methyl)carbamoyl]amino]-2-(2,6-dichlorophenyl)acetic acid Chemical compound C=1C=CC=CC=1C(=O)N(C)C(=O)NC(C(O)=O)C1=C(Cl)C=CC=C1Cl XSSSFECLQZXBHD-UHFFFAOYSA-N 0.000 description 1
- FMQWTLMQEILIOB-UHFFFAOYSA-N 2-[[benzoyl(methyl)carbamoyl]amino]-2-(4-methylphenyl)acetic acid Chemical compound C=1C=CC=CC=1C(=O)N(C)C(=O)NC(C(O)=O)C1=CC=C(C)C=C1 FMQWTLMQEILIOB-UHFFFAOYSA-N 0.000 description 1
- RLDWVLPMYGGTKU-UHFFFAOYSA-N 2-[[benzoyl(methyl)carbamoyl]amino]-2-(4-methylsulfanylphenyl)acetic acid Chemical compound C1=CC(SC)=CC=C1C(C(O)=O)NC(=O)N(C)C(=O)C1=CC=CC=C1 RLDWVLPMYGGTKU-UHFFFAOYSA-N 0.000 description 1
- QSUDAHNZTUQSCF-UHFFFAOYSA-N 2-[[ethoxycarbonyl(methyl)carbamoyl]amino]-2-(4-methylsulfanylphenyl)acetic acid Chemical compound C(C)OC(=O)N(C(NC(C(=O)O)C1=CC=C(C=C1)SC)=O)C QSUDAHNZTUQSCF-UHFFFAOYSA-N 0.000 description 1
- ZSSAXGUMEUVSOC-UHFFFAOYSA-N 2-cyclohex-3-en-1-ylacetic acid Chemical compound OC(=O)CC1CCC=CC1 ZSSAXGUMEUVSOC-UHFFFAOYSA-N 0.000 description 1
- JRVKWZTUEHWGRW-UHFFFAOYSA-N 2-ethylhexanoic acid;sodium Chemical compound [Na].CCCCC(CC)C(O)=O JRVKWZTUEHWGRW-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- UFQDKRWQSFLPQY-UHFFFAOYSA-N 4,5-dihydro-1h-imidazol-3-ium;chloride Chemical compound Cl.C1CN=CN1 UFQDKRWQSFLPQY-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- OFFFOVCCGHKJES-UHFFFAOYSA-N 4-methylthiadiazole Chemical compound CC1=CSN=N1 OFFFOVCCGHKJES-UHFFFAOYSA-N 0.000 description 1
- PIMQQGJMDMAZGT-UHFFFAOYSA-N 4-methylthiobenzaldehyde Chemical compound CC1=CC=C(C=S)C=C1 PIMQQGJMDMAZGT-UHFFFAOYSA-N 0.000 description 1
- ZMGMDXCADSRNCX-UHFFFAOYSA-N 5,6-dihydroxy-1,3-diazepan-2-one Chemical compound OC1CNC(=O)NCC1O ZMGMDXCADSRNCX-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- SORZJKLOTSHWIO-LLVKDONJSA-N C(CC)OC(=O)N(C(N[C@@H](C(=O)O)C1=CC=CC=C1)=O)C Chemical compound C(CC)OC(=O)N(C(N[C@@H](C(=O)O)C1=CC=CC=C1)=O)C SORZJKLOTSHWIO-LLVKDONJSA-N 0.000 description 1
- ABDYMGXXDGYACK-OAHLLOKOSA-N CC1=CC=C(C(=O)N(C(N[C@@H](C(=O)O)C2=CC=CC=C2)=O)C)C=C1 Chemical compound CC1=CC=C(C(=O)N(C(N[C@@H](C(=O)O)C2=CC=CC=C2)=O)C)C=C1 ABDYMGXXDGYACK-OAHLLOKOSA-N 0.000 description 1
- CMRMVMOSNXWVIC-SECBINFHSA-N COC(=O)N(C)C(=O)N[C@@H](C(O)=O)C1=CC=CC=C1 Chemical compound COC(=O)N(C)C(=O)N[C@@H](C(O)=O)C1=CC=CC=C1 CMRMVMOSNXWVIC-SECBINFHSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- 206010061259 Klebsiella infection Diseases 0.000 description 1
- 208000024233 Klebsiella infectious disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical group CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 1
- KZVRXPPUJQRGFN-UHFFFAOYSA-N N-carbamoylglycine Chemical compound NC(=O)NCC(O)=O KZVRXPPUJQRGFN-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- RUPGTYMAOGUQDN-UHFFFAOYSA-N O1C(=CC=C1)C(=O)N(C(NC(C(=O)O)CC1=CC=CS1)=O)C Chemical compound O1C(=CC=C1)C(=O)N(C(NC(C(=O)O)CC1=CC=CS1)=O)C RUPGTYMAOGUQDN-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical class OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- AZCVBVRUYHKWHU-MBNYWOFBSA-N Penicillin X Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=C(O)C=C1 AZCVBVRUYHKWHU-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000179948 Sarcophaga beta Species 0.000 description 1
- HEMHJVSKTPXQMS-DYCDLGHISA-M Sodium hydroxide-d Chemical compound [Na+].[2H][O-] HEMHJVSKTPXQMS-DYCDLGHISA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- JVVXZOOGOGPDRZ-SLFFLAALSA-N [(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine Chemical compound NC[C@]1(C)CCC[C@]2(C)C3=CC=C(C(C)C)C=C3CC[C@H]21 JVVXZOOGOGPDRZ-SLFFLAALSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- ZGUNAGUHMKGQNY-UHFFFAOYSA-N alpha-phenylglycine Chemical compound OC(=O)C(N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004161 brilliant blue FCF Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- VUAQGIMLSRMLIN-UHFFFAOYSA-N butyl n-carbonochloridoyl-n-methylcarbamate Chemical compound CCCCOC(=O)N(C)C(Cl)=O VUAQGIMLSRMLIN-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- UTZKZNGQZSXEMU-UHFFFAOYSA-N carboxymethylazanium;bromide Chemical compound Br.NCC(O)=O UTZKZNGQZSXEMU-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- LCFXLZAXGXOXAP-UHFFFAOYSA-N ethyl 2-cyano-2-hydroxyiminoacetate Chemical compound CCOC(=O)C(=NO)C#N LCFXLZAXGXOXAP-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- SNVGDEMHOMCIMA-UHFFFAOYSA-N ethyl n-carbonochloridoyl-n-methylcarbamate Chemical compound CCOC(=O)N(C)C(Cl)=O SNVGDEMHOMCIMA-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000027096 gram-negative bacterial infections Diseases 0.000 description 1
- 208000027136 gram-positive bacterial infections Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000006263 metalation reaction Methods 0.000 description 1
- FQYSDSAQYQMXHG-UHFFFAOYSA-N methoxycarbonyl(methyl)carbamic acid;hydrochloride Chemical compound Cl.COC(=O)N(C)C(O)=O FQYSDSAQYQMXHG-UHFFFAOYSA-N 0.000 description 1
- UFEJKYYYVXYMMS-UHFFFAOYSA-N methylcarbamic acid Chemical compound CNC(O)=O UFEJKYYYVXYMMS-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- DZJQBXTZUNEREU-UHFFFAOYSA-N n-(3-chloropropanoyl)-n-methylcarbamoyl chloride Chemical compound ClC(=O)N(C)C(=O)CCCl DZJQBXTZUNEREU-UHFFFAOYSA-N 0.000 description 1
- HLLRTKUOBBWPGS-UHFFFAOYSA-N n-(4-chlorobutanoyl)-n-methylcarbamoyl chloride Chemical compound ClC(=O)N(C)C(=O)CCCCl HLLRTKUOBBWPGS-UHFFFAOYSA-N 0.000 description 1
- RDRHJSCUWXKCDK-UHFFFAOYSA-N n-(furan-2-carbonyl)-n-methylcarbamoyl chloride Chemical compound ClC(=O)N(C)C(=O)C1=CC=CO1 RDRHJSCUWXKCDK-UHFFFAOYSA-N 0.000 description 1
- DHKUJWGVJZEAPZ-UHFFFAOYSA-N n-acetyl-n-benzylcarbamoyl chloride Chemical compound CC(=O)N(C(Cl)=O)CC1=CC=CC=C1 DHKUJWGVJZEAPZ-UHFFFAOYSA-N 0.000 description 1
- XHLLMVSEBKZODD-UHFFFAOYSA-N n-acetyl-n-methylcarbamoyl chloride Chemical compound CC(=O)N(C)C(Cl)=O XHLLMVSEBKZODD-UHFFFAOYSA-N 0.000 description 1
- FNUXALAIXBYOCN-UHFFFAOYSA-N n-methyl-n-(4-methyl-3-nitrobenzoyl)carbamoyl chloride Chemical compound ClC(=O)N(C)C(=O)C1=CC=C(C)C([N+]([O-])=O)=C1 FNUXALAIXBYOCN-UHFFFAOYSA-N 0.000 description 1
- RRHVENZRSNKBSG-UHFFFAOYSA-N n-methyl-n-(4-methylbenzoyl)carbamoyl chloride Chemical compound ClC(=O)N(C)C(=O)C1=CC=C(C)C=C1 RRHVENZRSNKBSG-UHFFFAOYSA-N 0.000 description 1
- GRRYSIXDUIAUGY-UHFFFAOYSA-N n-methylcarbamoyl chloride Chemical compound CNC(Cl)=O GRRYSIXDUIAUGY-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- FDJABJJEKWDNQO-UHFFFAOYSA-N pentane;propan-2-one Chemical compound CC(C)=O.CCCCC FDJABJJEKWDNQO-UHFFFAOYSA-N 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NONJJLVGHLVQQM-JHXYUMNGSA-N phenethicillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C(C)OC1=CC=CC=C1 NONJJLVGHLVQQM-JHXYUMNGSA-N 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- WNLCVVYFMVDPAA-UHFFFAOYSA-N propan-2-yl n-carbonochloridoyl-n-methylcarbamate Chemical compound CC(C)OC(=O)N(C)C(Cl)=O WNLCVVYFMVDPAA-UHFFFAOYSA-N 0.000 description 1
- YNWGWXZWWGYIKG-UHFFFAOYSA-N propyl N-carbonochloridoyl-N-methylcarbamate Chemical compound C(CC)OC(=O)N(C(=O)Cl)C YNWGWXZWWGYIKG-UHFFFAOYSA-N 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/58—Y being a hetero atom
- C07C275/60—Y being an oxygen atom, e.g. allophanic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2025415A DE2025415C3 (de) | 1970-05-25 | 1970-05-25 | Verfahren zur Herstellung von cyclischen Acylureido-Penicillinen |
| DE19712104579 DE2104579C3 (de) | 1971-02-01 | 1971-02-01 | Cyclische Acylureidopenicilline und sie enthaltende Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DD91496A5 DD91496A5 (de) | 1972-07-20 |
| DD91496B3 true DD91496B3 (de) | 1988-01-27 |
Family
ID=25759180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD71155308A DD91496B3 (de) | 1970-05-25 | 1971-05-24 | Verfahren zur herstellung neuer penicilline |
Country Status (26)
| Country | Link |
|---|---|
| JP (1) | JPS55390B1 (cs) |
| AT (1) | AT306924B (cs) |
| BE (1) | BE767648A (cs) |
| BG (1) | BG23753A3 (cs) |
| CA (1) | CA932722A (cs) |
| CH (1) | CH571524A5 (cs) |
| CS (1) | CS185564B2 (cs) |
| CY (1) | CY830A (cs) |
| DD (1) | DD91496B3 (cs) |
| DK (1) | DK134438C (cs) |
| EG (1) | EG10490A (cs) |
| ES (4) | ES391533A1 (cs) |
| FI (1) | FI54485C (cs) |
| FR (1) | FR2100682B1 (cs) |
| GB (1) | GB1301962A (cs) |
| IE (1) | IE35404B1 (cs) |
| IL (1) | IL36904A (cs) |
| KE (1) | KE2591A (cs) |
| LU (1) | LU63204A1 (cs) |
| NL (1) | NL172659C (cs) |
| NO (1) | NO141759C (cs) |
| PH (1) | PH12110A (cs) |
| RO (1) | RO59290A (cs) |
| SE (1) | SE395895B (cs) |
| SU (1) | SU420181A3 (cs) |
| YU (1) | YU35889B (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2260118C2 (de) * | 1972-12-08 | 1982-06-03 | Bayer Ag, 5090 Leverkusen | Penicilline sowie ihre Verwendung als Arzneimittel |
| US4039673A (en) | 1973-10-30 | 1977-08-02 | Bayer Aktiengesellschaft | Penicillins and cephalosporins and their production |
| DE2354219A1 (de) * | 1973-10-30 | 1975-05-07 | Bayer Ag | Beta-lactam-antibiotica, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| GB1486349A (en) * | 1974-11-28 | 1977-09-21 | Bayer Ag | Beta-lactam antibiotics process for their preparation and their use as medicaments |
| GB1584400A (en) * | 1976-12-24 | 1981-02-11 | Bayer Ag | (2-oxo-imidazoliden-1-yl(carbonylamino)-acetamido-cephalosporins and penicillins |
| KR860000300B1 (ko) * | 1983-12-19 | 1986-03-31 | 보령제약 주식회사 | 아실우레이도 페니실린 유도체의 제조방법 |
-
1971
- 1971-04-23 CH CH599171A patent/CH571524A5/xx not_active IP Right Cessation
- 1971-05-18 BG BG017581A patent/BG23753A3/xx unknown
- 1971-05-19 CS CS7100003647A patent/CS185564B2/cs unknown
- 1971-05-19 EG EG212/71A patent/EG10490A/xx active
- 1971-05-20 SU SU1660129A patent/SU420181A3/ru active
- 1971-05-21 IE IE644/71A patent/IE35404B1/xx unknown
- 1971-05-21 LU LU63204D patent/LU63204A1/xx unknown
- 1971-05-21 FI FI1402/71A patent/FI54485C/fi active
- 1971-05-24 NO NO1946/71A patent/NO141759C/no unknown
- 1971-05-24 PH PH12494A patent/PH12110A/en unknown
- 1971-05-24 SE SE7106668A patent/SE395895B/xx unknown
- 1971-05-24 DK DK251171A patent/DK134438C/da not_active IP Right Cessation
- 1971-05-24 DD DD71155308A patent/DD91496B3/de unknown
- 1971-05-24 YU YU1296/71A patent/YU35889B/xx unknown
- 1971-05-24 IL IL7136904A patent/IL36904A/xx unknown
- 1971-05-25 NL NLAANVRAGE7107176,A patent/NL172659C/xx not_active IP Right Cessation
- 1971-05-25 ES ES391533A patent/ES391533A1/es not_active Expired
- 1971-05-25 BE BE767648A patent/BE767648A/xx not_active IP Right Cessation
- 1971-05-25 FR FR7118933A patent/FR2100682B1/fr not_active Expired
- 1971-05-25 JP JP3524571A patent/JPS55390B1/ja active Pending
- 1971-05-25 AT AT450571A patent/AT306924B/de not_active IP Right Cessation
- 1971-05-25 CA CA113785A patent/CA932722A/en not_active Expired
- 1971-05-25 CY CY830A patent/CY830A/xx unknown
- 1971-05-25 RO RO67015A patent/RO59290A/ro unknown
- 1971-05-25 GB GB1688171A patent/GB1301962A/en not_active Expired
-
1973
- 1973-02-16 ES ES411674A patent/ES411674A1/es not_active Expired
- 1973-02-16 ES ES411675A patent/ES411675A1/es not_active Expired
- 1973-02-16 ES ES411676A patent/ES411676A1/es not_active Expired
-
1975
- 1975-12-22 KE KE2591*UA patent/KE2591A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD106044B3 (de) | Verfahren zur herstellung neuer penicilline | |
| DE2744135A1 (de) | Cephalosporinderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
| DE2439880A1 (de) | Antibiotika und verfahren zu ihrer herstellung | |
| DD106045B3 (de) | Verfahren zur herstellung neuer penicilline | |
| DE2224651A1 (cs) | ||
| DD91496B3 (de) | Verfahren zur herstellung neuer penicilline | |
| DE2104580A1 (en) | Alpha-3-acylureido benzyl penicillins antibacterial agents esp - against klebsiella | |
| DE2312041A1 (de) | Penicilline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel | |
| EP0000392B1 (de) | Cephalosporin und Penicillin-derivate, Verfahren zu deren Herstellung, und deren pharmazeutische Präparate | |
| DD91497B3 (de) | Verfahren zur herstellung neuer penicilline | |
| CH626370A5 (en) | Process for the preparation of the syn isomer or of a mixture of syn and anti isomers of 7beta-acylamidoceph-3-em-4-carboxylic acids with antibiotic activity | |
| DE2025415C3 (de) | Verfahren zur Herstellung von cyclischen Acylureido-Penicillinen | |
| DE2600842C2 (cs) | ||
| EP0035161B1 (de) | Cephalosporine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| CH633802A5 (de) | Verfahren zur herstellung neuer beta-lactam-antibiotica. | |
| EP0075169A1 (de) | Beta-Lactam Antibiotica, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
| DE1929997C2 (de) | Acylureidopenicilline, Verfahren zu ihrer Herstellung und antibakterielle Mittel, die diese Verbindungen enthalten | |
| DE2104579C3 (de) | Cyclische Acylureidopenicilline und sie enthaltende Arzneimittel | |
| DE2025414A1 (en) | Alpha-3-acylureido benzyl penicillins antibacterial agents esp - against klebsiella | |
| DE2050087A1 (en) | Alpha-benzamido-ampicillin-type derivs - with antibacterial activity | |
| DE2539214C2 (de) | 7-Methoxythienyl-ureido-cephalosporin und dieses enthaltendes Arzneimittel | |
| DE2066157C2 (de) | Acylureidopenicilline | |
| EP0054677B1 (de) | Neue Cephalosporine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| AT367061B (de) | Verfahren zur herstellung von neuen antibiotischen verbindungen | |
| DE2236422C2 (de) | Cephalosporinverbindungen und Verfahren zu deren Herstellung |